Ensho Therapeutics
Ensho Therapeutics reported $7,281,948 raised in an SEC Form D filed on 2026-10-15. State of the filing: New Jersey.
- Industry
- Biotechnology
- Location
- New Jersey
About
Ensho Therapeutics appears in Section 3 of the Raise Track Update of 2026-10-16, which lists new SEC Form D filings. The filing reports $7,281,948 raised and gives New Jersey as the state. The industry on the filing is Biotechnology. Related persons named on the filing: Danielle Fry (executive officer, Woodcliff Lake, New Jersey); Arash Rassoulpour (director, Woodcliff Lake, New Jersey); Carlos Solorzano (director, Woodcliff Lake, New Jersey); Eric Pham (director, Woodcliff Lake, New Jersey); Gerhard Hagn (director, Woodcliff Lake, New Jersey); Neena Bitritto-Garg (director, Woodcliff Lake, New Jersey); Tariq Kassum (director, Woodcliff Lake, New Jersey). Filing: https://www.sec.gov/Archives/edgar/data/2032849/000203284926000002/0002032849-26-000002-index.htm
This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Form D 2026 | 2026-10-15 | $7.28M |
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/2032849/000203284926000002/0002032849-26-000002-index.htm
Type: sec filing. Accessed 2026-10-16.
SEC Form D for Ensho Therapeutics, Inc. EDGAR filing date 2026-10-15. Signed 2026-10-15. First sale 2026-10-02. Total amount sold $7,281,948 of an offering amount of $15,604,179. 7 investors already invested. Issuer address city is Woodcliff Lake, New Jersey. Jurisdiction of incorporation is Delaware. Entity type on the form is Corporation. Year of incorporation on the form: 2024. The form does not name the purchasers or a round type. Street addresses are not published. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-16/
Type: other verified public source. Accessed 2026-10-16.
Raise Track Update for 2026-10-16, Section 3. Lists Ensho Therapeutics, state NEW JERSEY, industry Biotechnology, amount raised $7,281,948.